| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdc2787a32cce910a72605c3d3b8133c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate |
2022-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_156114c76e73f2bc53def2d72eb75a95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e9b35e2e091310ba272efdf4d473a91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f682f9f2f34da3823bc55b6c9cb054e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c49e079e08a09e38b5e939a97b41625
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5a33159ced5be14cf829fb7f985bb68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2096f29a9a33b85f9a292e1cb1c0484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c58041a46a2a665d0cb257b287dc4d0 |
| publicationDate |
2022-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022266190-A1 |
| titleOfInvention |
Substituted pyrimidinyl-pyrazoles as cdk2 inhibitors |
| abstract |
The present disclosure provides a compound represented by structural formula (I): (I), or a pharmaceutically acceptable salt thereof useful for treating a cancer. |
| priorityDate |
2021-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |